News
Posters presented at the 2023 Fall Clinical Dermatology Conference evaluated how label warnings may affect new treatment initiation and real-word switching patterns for patients starting risankizumab.
Some researchers spend years working on architectures and technologies that are never adopted by industry or that are used only as transition technologies. Witness the scores who worked on ...
7 Reasons to Not Use MPLS and 4 Better Alternatives Your email has been sent There are a few cases for using MPLS — but most have moved on from multiprotocol label switching and found a cheaper, more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results